View More
Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
Hear Stephen A. Harrison, MD, COL (Ret.), FAASLD, weigh the latest perspectives on wet biomarkers, imaging, and combination tests in NASH, including their use in:
Download the slides from this podcast at: https://www.clinicaloptions.com/internal-medicine/programs/2019-nash-hot-topics/noninvasive-testing-now-and-in-the-future/slideset
See more NASH topics at: https://www.clinicaloptions.com/internal-medicine/programs/2019-nash-hot-topics
American Gastroenterological Association (AGA)
4930 Del Ray Avenue
Bethesda, MD 20814
Phone: (301) 654-2055
Fax: (301) 654-5920
Email: member@gastro.org
Hear CCO faculty Philip Newsome discuss the agents in late-phase clinical trials and their potential use in treatment of NASH and fibrosis
Philip N. Newsome, PhD, FRCPE
Released: February 12, 2020
CCO faculty Dr Juan Frias discusses the agents in late-phase clinical trials and their potential use in treatment of NASH and fibrosis
Juan Pablo Frias, MD, FACE
Released: February 5, 2020
Juan Frias and Philip Newsome: Learn about the agents in phase II and III clinical trials and their potential use in treatment.
Juan Pablo Frias, MD, FACE
Philip N. Newsome, PhD, FRCPE
Released: January 28, 2020
Hear CCO faculty Rita Basu, MD, weigh the latest perspectives on wet biomarkers, imaging, and combination tests
Rita Basu, MD
Released: January 23, 2020
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.